Showing results (91-100 of 100) with videos related to
Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
European Journal of Neurology|September 22, 2020
Early neurological deterioration following thrombolysis for minor stroke with isolated internal carotid artery occlusionN Boulenoir, G Turc, H Henon, et al.Revue De Chirurgie Orthopedique Et Reparatrice De L'Appareil Moteur|January 1, 1987
[Syringomyelia and scoliosis in children and adolescents. Apropos of 14 cases]J Depotter, P Rigault, J C Pouliquen, et al.Neurology|September 28, 2005
Prevention of venous thrombosis in patients with acute intracerebral hemorrhageK Lacut, L Bressollette, G Le Gal, et al.Revue Neurologique|January 5, 2001
[Pharmaco-epidemiological study on the prophylactic treatment of migraine. National inquiry on attitude to prescription practices by primary care physicians and neurologists in Franceø]M Lantéri-Minet, H Alchaar, G Besson, et al.La Revue De Medecine Interne|November 26, 2016
[Acid sphingomyelinase deficiency (Niemann-Pick disease type B) in adulthood: A retrospective multicentric study of 28 adult cases]O Lidove, N Belmatoug, R Froissart, et al.European Journal of Neurology|November 1, 2008
Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective studyJ Gil, B Funalot, A Verschueren, et al.Journal of Virology|April 1, 1997
Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutationS Rana, G Besson, D G Cook, et al.Revue Neurologique|April 22, 2014
[Cerebrotendinous xanthomatosis: a multicentric retrospective study of 15 adults, clinical and paraclinical typical and atypical aspects]C Lionnet, C Carra, X Ayrignac, et al.European Journal of Neurology|July 31, 2013
A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohortO Outteryck, J C Ongagna, B Brochet, et al.BMC Medical Research Methodology|May 31, 2022
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosisM Lefort, S Sharmin, J B Andersen, et al.Pageof 10